SHL Telemedicine Price to Sales Ratio 2022-2023 | SHLT
SHL Telemedicine P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2024-05-03 | 4.65 | inf |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.068B | $0.057B |
SHL Telemedicine Ltd is engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Its solutions for healthcare professionals include: CHF monitoring service which supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease and Readmission Solutions for reducing heart-related readmissions. SHL Telemedicine Ltd is based in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.527B | 19.51 |
Inspire Medical Systems (INSP) | United States | $7.610B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.451B | 0.00 |
Axonics (AXNX) | United States | $3.424B | 0.00 |
10x Genomics (TXG) | United States | $3.133B | 0.00 |
Azenta (AZTA) | United States | $2.932B | 238.96 |
Olink Holding AB (publ) (OLK) | Sweden | $2.862B | 0.00 |
Enovis (ENOV) | United States | $2.859B | 21.19 |
Hims & Hers Health (HIMS) | United States | $2.622B | 0.00 |
Privia Health (PRVA) | United States | $2.184B | 96.89 |
Schrodinger (SDGR) | United States | $1.677B | 0.00 |
Omnicell (OMCL) | United States | $1.345B | 46.49 |
Phreesia (PHR) | United States | $1.255B | 0.00 |
Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
Standard BioTools (LAB) | United States | $0.734B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.701B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.635B | 0.00 |
Talkspace (TALK) | United States | $0.531B | 0.00 |
Health Catalyst (HCAT) | United States | $0.386B | 0.00 |
Pulmonx (LUNG) | United States | $0.361B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.331B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.319B | 0.00 |
Butterfly Network (BFLY) | United States | $0.192B | 0.00 |
P3 Health Partners (PIII) | United States | $0.189B | 0.00 |
Outset Medical (OM) | United States | $0.155B | 0.00 |
American Well (AMWL) | United States | $0.151B | 0.00 |
Augmedix (AUGX) | United States | $0.130B | 0.00 |
MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
TruBridge (TBRG) | United States | $0.125B | 5.32 |
111 (YI) | China | $0.094B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
NantHealth (NHIQ) | United States | $0.058B | 0.00 |
HeartBeam (BEAT) | United States | $0.058B | 0.00 |
Zepp Health (ZEPP) | China | $0.056B | 0.00 |
Movano (MOVE) | United States | $0.050B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Syra Health (SYRA) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |